| Product Code: ETC9388873 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Parkinsons Disease Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Parkinsons Disease Market - Industry Life Cycle |
3.4 South Africa Parkinsons Disease Market - Porter's Five Forces |
3.5 South Africa Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 South Africa Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 South Africa Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 South Africa Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 South Africa Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 South Africa Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in South Africa due to an aging population. |
4.2.2 Growing awareness and diagnosis rates of Parkinson's disease in the country. |
4.2.3 Advancements in medical research and technology leading to better treatment options for Parkinson's patients. |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for Parkinson's disease management in certain regions of South Africa. |
4.3.2 High costs associated with Parkinson's disease treatment and medications. |
4.3.3 Lack of skilled healthcare professionals specializing in Parkinson's disease care in the country. |
5 South Africa Parkinsons Disease Market Trends |
6 South Africa Parkinsons Disease Market, By Types |
6.1 South Africa Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 South Africa Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 South Africa Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 South Africa Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 South Africa Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 South Africa Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 South Africa Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 South Africa Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 South Africa Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 South Africa Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 South Africa Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 South Africa Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 South Africa Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 South Africa Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 South Africa Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 South Africa Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 South Africa Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Africa Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Africa Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 South Africa Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 South Africa Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 South Africa Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 South Africa Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 South Africa Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 South Africa Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 South Africa Parkinsons Disease Market Import-Export Trade Statistics |
7.1 South Africa Parkinsons Disease Market Export to Major Countries |
7.2 South Africa Parkinsons Disease Market Imports from Major Countries |
8 South Africa Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of Parkinson's disease diagnosis in South Africa. |
8.2 Percentage increase in government funding for Parkinson's disease research and treatment. |
8.3 Number of clinical trials and research studies focused on Parkinson's disease in South Africa. |
9 South Africa Parkinsons Disease Market - Opportunity Assessment |
9.1 South Africa Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 South Africa Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 South Africa Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 South Africa Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 South Africa Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 South Africa Parkinsons Disease Market - Competitive Landscape |
10.1 South Africa Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 South Africa Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here